Connective Tissue Diseases
"Connective Tissue Diseases" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A heterogeneous group of disorders, some hereditary, others acquired, characterized by abnormal structure or function of one or more of the elements of connective tissue, i.e., collagen, elastin, or the mucopolysaccharides.
| Descriptor ID |
D003240
|
| MeSH Number(s) |
C17.300
|
| Concept/Terms |
Connective Tissue Diseases- Connective Tissue Diseases
- Connective Tissue Disease
- Disease, Connective Tissue
- Diseases, Connective Tissue
|
Below are MeSH descriptors whose meaning is more general than "Connective Tissue Diseases".
Below are MeSH descriptors whose meaning is more specific than "Connective Tissue Diseases".
This graph shows the total number of publications written about "Connective Tissue Diseases" by people in this website by year, and whether "Connective Tissue Diseases" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2011 | 1 | 0 | 1 |
| 2013 | 0 | 1 | 1 |
| 2014 | 1 | 0 | 1 |
| 2015 | 2 | 0 | 2 |
| 2017 | 9 | 2 | 11 |
| 2018 | 10 | 5 | 15 |
| 2019 | 3 | 0 | 3 |
| 2020 | 3 | 0 | 3 |
| 2021 | 3 | 0 | 3 |
To return to the timeline, click here.
Below are the most recent publications written about "Connective Tissue Diseases" by people in Profiles.
-
A real-world study of immune thrombocytopenia management during the COVID-19 pandemic in the UK. Br J Haematol. 2022 01; 196(2):351-355.
-
COVID-19 infection among autoimmune rheumatic disease patients: Data from an observational study and literature review. J Autoimmun. 2021 09; 123:102687.
-
Interstitial Lung Disease after COVID-19. Am J Respir Crit Care Med. 2021 05 15; 203(10):1314-1315.
-
Effects of face masks on oxygen saturation and functional measures in patients with connective tissue disorder-associated interstitial lung disease. Ann Rheum Dis. 2021 11; 80(11):1497-1498.
-
COVID-19 and rheumatic musculoskeletal disease patients: infection rates, attitudes and medication adherence in an Irish population. Rheumatology (Oxford). 2021 02 01; 60(2):902-906.
-
The impact of COVID-19 on rare and complex connective tissue diseases: the experience of ERN ReCONNET. Nat Rev Rheumatol. 2021 03; 17(3):177-184.
-
Telemedicine in rheumatology: a reliable approach beyond the pandemic. Rheumatology (Oxford). 2021 01 05; 60(1):366-370.
-
Impact of COVID-19 on Clinical Operations and Management of Patients in a Singapore Immunodermatology Unit during the 'Circuit-Breaker' Period and Beyond. Ann Acad Med Singap. 2020 11; 49(11):919-921.
-
Clinical, Serological, and Histopathological Similarities Between Severe COVID-19 and Acute Exacerbation of Connective Tissue Disease-Associated Interstitial Lung Disease (CTD-ILD). Front Immunol. 2020; 11:587517.
-
COVID-19 in Patients With Connective Tissue Disease-related Interstitial Lung Disease. J Rheumatol. 2021 03; 48(3):468-470.